Final Colorado PDMP Training and Legislative Update Webinar to be held Sept. 12

Having trouble viewing this email? View it as a Web page.

CO DORA DPO Color  Logo Lock Up

Final Colorado PDMP Training and Legislative Update Webinar to be held Sept. 12

We apologize for the multiple emails, but due to high demand, the Colorado Department of Regulatory Agencies, Division of Professions and Occupations (Division) will hold a third Prescription Drug Monitoring Program (PDMP) Training and Legislative Update webinar. The content of this webinar will be the same as the content of the August 23 and August 30, 2022 webinars. It will include training and resources regarding registration and use of the Colorado PDMP and will discuss several statutory changes that take effect in 2022.


A recording and a copy of the presentation slides from the earlier presentation is posted to the DORA PDMP Training webpage at https://dpo.colorado.gov/PDMP/Training. Additionally, a Frequently Asked Questions document concerning the topics covered in these webinars will be published to the DORA PDMP Training webpage in the coming weeks.

  • Who? Prescribers, pharmacists, delegate PDMP users, and other stakeholders
  • What? PDMP training and education session regarding PDMP registration requirements, use of the PDMP, delegate registration and use of the PDMP, and program updates due to recent legislation.
  • Where? Virtual - register here. Please note that registration is limited to 500 participants.
  • When? Sept. 12, 2022; 4 p.m.
  • Why? Recent legislation made several statutory changes to the Colorado PDMP that take effect in 2022, including updates concerning delegate access and statutory requirements that prescribers query the PDMP before writing certain opioid and benzodiazepine prescriptions.


Legislative Updates

Colorado Senate Bill 22-027 and House Bill 22-1115 enact several statutory updates regarding the Colorado Prescription Drug Monitoring Program that take effect in 2022:

  • SB 22-027 clarifies that all DEA-licensed prescribers and all pharmacists licensed in Colorado are required to register and maintain a user account with the Colorado PDMP.
  • HB 22-1115 removes restrictions on the number of delegate users a DEA-licensed practitioner or pharmacist may authorize to query the PDMP on the prescriber’s or pharmacist’s behalf.
  • SB 22-027 and HB 22-1115 clarify that each practitioner or the practitioner's delegate is required to query the PDMP prior to prescribing an opioid unless the patient receiving the prescription:
    • Is receiving the opioid in a hospital, skilled nursing facility, residential facility, or correctional facility;
    • Has been diagnosed with cancer and is experiencing cancer-related pain;
    • Is undergoing palliative care or hospice care;
    • Is experiencing post-surgical pain that, because of the nature of the procedure, is expected to last more than fourteen days;
    • Is receiving treatment during a natural disaster or during an incident where mass casualties have taken place; or
    • Has received only a single dose to relieve pain for a single test or procedure.
  • SB 22-027 and HB 22-1115 clarify that each practitioner or the practitioner's designee shall query the program before prescribing a benzodiazepine to a patient unless the benzodiazepine is prescribed to treat a patient:
    • In hospice;
    • To treat epilepsy, a seizure or seizure disorder, a suspected seizure disorder, spasticity, alcohol withdrawal, or a neurological condition, including a posttraumatic brain injury or catatonia.


PDMP Task Force Annual Report

SB 22-027 requires the PDMP Task Force to evaluate and make recommendations to the DORA Executive Director, after engaging in a stakeholder process, regarding balancing the PDMP as a health care tool with the enforcement of PDMP statutory requirements.


For the 2021-2022 PDMP Task Force Annual Report, the DORA Executive Director requested that the PDMP Task Force:

  • Evaluate the Effects of Allowing Law Enforcement Access to PDMP data without Requiring a Subpoena or Court Order
  • Evaluate Effectiveness of Unsolicited Reporting to Licensing Boards of Licensees’ Prescribing Activity


The PDMP Task Force submitted its Annual Report to the Colorado General Assembly on July 1, 2022. The report can be found at: http://www.leg.state.co.us/library/reports.nsf/reports.xsp. In the “Statutory Cite” pick list, select 12-280-409(2) to find the 2021-2022 PDMP Task Force Annual Report.

 

Do not reply to this email – this is not a monitored inbox